Recently we found that CD8+CD38high population is expanded in subset of patients with SLE who have increased rates of infections and these cells had decreased cytotoxic capacity, degranulation and expression of cytolytic enzymes [87]. The gene discussed is CD8A; the disease is systemic lupus erythematosus.